10-Q Filing

ROCK CREEK PHARMACEUTICALS, INC. CIK: 776008 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-048584`
Period End Date	20140630
Filing Date	20140811
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	rcpi-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 56 Cash Flow Statement 53 Stockholders Equity 15

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	274.80M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	274.80M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	172.38M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	181.86M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	181.86M	shares	Point-in-time
Receivable from sale of licensing rights	`ReceivableFromSaleOfLicensingRights`	$18.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	172.38M	shares	Point-in-time
Receivable from sale of licensing rights	`ReceivableFromSaleOfLicensingRights`	-	USD	Point-in-time
Note receivable-short term	`NotesAndLoansReceivableNetCurrent`	$70.00K	USD	Point-in-time
Note receivable-short term	`NotesAndLoansReceivableNetCurrent`	$66.00K	USD	Point-in-time
Inventories, net	`InventoryNet`	$3.28M	USD	Point-in-time
Inventories, net	`InventoryNet`	$3.47M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.57M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$933.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.03M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$394.00K	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$399.00K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$472.00K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$437.00K	USD	Point-in-time
Note receivable-long-term-net	`NotesAndLoansReceivableNetNoncurrent`	$517.00K	USD	Point-in-time
Note receivable-long-term-net	`NotesAndLoansReceivableNetNoncurrent`	$208.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
Assets held for sale of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$69.00K	USD	Point-in-time
Assets held for sale of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$69.00K	USD	Point-in-time
Total assets	`Assets`	$10.95M	USD	Point-in-time
Total assets	`Assets`	$9.62M	USD	Point-in-time
Accounts payable, trade	`AccountsPayableTradeCurrent`	$2.08M	USD	Point-in-time
Accounts payable, trade	`AccountsPayableTradeCurrent`	$1.64M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.81M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.59M	USD	Point-in-time
Due to stockholders	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Due to stockholders	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$29.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.97M	USD	Point-in-time
Commitments and contingencies (note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$286.23M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$271.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-264.37M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-286.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-654.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.62M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$10.95M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueGoodsNet`	$2.52M	USD	1 Quarter
Net sales	`SalesRevenueGoodsNet`	$5.03M	USD	2 Qtrs
Net sales	`SalesRevenueGoodsNet`	$1.84M	USD	2 Qtrs
Net sales	`SalesRevenueGoodsNet`	$721.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$1.49M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$782.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$325.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$2.88M	USD	2 Qtrs
Gross profit	`GrossProfit`	$396.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.03M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.15M	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.06M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.43M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$2.28M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$1.67M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$848.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.65M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$20.15M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.85M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.50M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$722.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$783.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.83M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$19.19M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$23.32M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$9.85M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-22.26M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-8.82M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-12.44M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-17.05M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingExpense`	$268.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingExpense`	$-99.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingExpense`	$-101.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingExpense`	$276.00K	USD	2 Qtrs
Net loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.71M	USD	1 Quarter
Net loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.72M	USD	1 Quarter
Net loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.54M	USD	2 Qtrs
Net loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.95M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-8.72M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-12.71M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-22.54M	USD	2 Qtrs
Net loss	`IncomeLossFromContinuingOperations`	$-16.95M	USD	2 Qtrs
Net loss basic and diluted per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	2 Qtrs
Net loss basic and diluted per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Net loss basic and diluted per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Net loss basic and diluted per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	166.49M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	178.13M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	166.49M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	181.86M	shares	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net loss	`IncomeLossFromContinuingOperations`	$-8.72M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-12.71M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-22.54M	USD	2 Qtrs
Net loss	`IncomeLossFromContinuingOperations`	$-16.95M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$87.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$161.00K	USD	2 Qtrs
Provision for inventory obsolescence	`InventoryWriteDown`	$8.00K	USD	2 Qtrs
Provision for inventory obsolescence	`InventoryWriteDown`	$-2.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.04M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$8.25M	USD	2 Qtrs
Current assets	`IncreaseDecreaseInOperatingAssets`	$-841.00K	USD	2 Qtrs
Current assets	`IncreaseDecreaseInOperatingAssets`	$-1.14M	USD	2 Qtrs
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$4.18M	USD	2 Qtrs
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$3.71M	USD	2 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.36M	USD	2 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.72M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.00K	USD	2 Qtrs
Proceeds from sale of licensing rights	`ProceedsFromSaleOfLicensingRights`	$18.00K	USD	2 Qtrs
Proceeds from sale of licensing rights	`ProceedsFromSaleOfLicensingRights`	$16.00K	USD	2 Qtrs
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$16.00K	USD	2 Qtrs
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-29.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.10M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.11M	USD	2 Qtrs
Proceeds from stock option and warrant exercise	`ProceedsFromStockOptionsExercised`	$4.17M	USD	2 Qtrs
Proceeds from stock option and warrant exercise	`ProceedsFromStockOptionsExercised`	$30.00K	USD	2 Qtrs
Payments on long-term debt and capital lease obligation	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	$-7.00K	USD	2 Qtrs
Payments on long-term debt and capital lease obligation	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	-	USD	2 Qtrs
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.28M	USD	2 Qtrs
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$23.00K	USD	2 Qtrs
MSA escrow deposits	`DepositsToMsaEscrow`	$1.00K	USD	2 Qtrs
MSA escrow deposits	`DepositsToMsaEscrow`	-	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$-10.68M	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$-103.00K	USD	2 Qtrs
Net cash flows used in operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.27M	USD	2 Qtrs
Net cash flows used in operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-29.00K	USD	2 Qtrs
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-29.00K	USD	2 Qtrs
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-1.27M	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-132.00K	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-11.95M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.18M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.18M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$-654.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$6.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$9.97M	USD	Point-in-time
Stock issuance	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Stock issuance	`StockIssuedDuringPeriodValueNewIssues`	$5.11M	USD	1 Quarter
Stock issuance (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	5.10M	shares	1 Quarter
Warrant and option exercise	`WarrantAndOptionExercise`	-	USD	1 Quarter
Warrant and option exercise	`WarrantAndOptionExercise`	$4.17M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.54M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.08M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-9.83M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.71M	USD	1 Quarter
Balances	`StockholdersEquity`	$-654.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$6.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$9.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.